Bevacizumab Beyond Progression (BBP)

NCT01740258 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Malignant Glioma
Grade 4 Malignant Glioma
Glioblastoma
Gliosarcoma

Interventions

RADIATION: Radiation Therapy
DRUG: Temozolomide
DRUG: Bevacizumab

Sponsor

Duke University

Collaborators

[object Object]